Breastfeeding is not a risk factor for clinical severity in Autism spectrum disorder in children from the ELENA cohort

Sci Rep. 2023 Jan 16;13(1):816. doi: 10.1038/s41598-022-27040-x.

Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental disorder that results from a complex interaction between genes and environment. Breastfeeding (BF) is thought to promote healthy cognitive development, and a body of research has suggested that it may also protect against ASD. Our objectives were to identify the relationship between the initiation and duration of BF and the severity of clinical presentation in ASD. Data were collected from 243 children with a confirmed diagnosis of ASD followed in the ELENA cohort. Clinical severity was measured according to multiple dimensions using standardised tools. The frequency of the initiation of BF was comparable to that of the general population and the rate of children still being breastfed at six months of age was higher. Our results did not indicate a contribution of initiation or duration of BF to the prevention of clinical severity of ASD. We discuss our results in the light of possible methodological limitations of previous reports of an association between BF and ASD.Clinical Trial Registration: NCT02625116.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autism Spectrum Disorder* / epidemiology
  • Autism Spectrum Disorder* / etiology
  • Breast Feeding*
  • Child
  • Cognition
  • Female
  • Health Status
  • Humans
  • Risk Factors

Associated data

  • ClinicalTrials.gov/NCT02625116